Showing results (71-80 of 102) with videos related to
Sort By:
Pageof 11
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 3, 2010
Efficacy and safety/toxicity study of recombinant vaccinia virus JX-594 in two immunocompetent animal models of gliomaXueQing Lun, Jennifer Chan, Hongyuan Zhou, et al.Neuro-Oncology|September 1, 2025
Phase IB Study of Avelumab and Whole Brain Radiotherapy (WBRT) in Patients with Leptomeningeal Disease (LMD) from Solid Tumors: Results and Molecular AnalysesYolanda Piña, Vincent Law, Solmaz Sahebjam, et al.Cancer Research|March 11, 2010
Oncolytic viral therapy for prostate cancer: efficacy of reovirus as a biological therapeuticChandini M Thirukkumaran, Michael J Nodwell, Kensuke Hirasawa, et al.Nature Communications|February 16, 2017
Smac mimetics synergize with immune checkpoint inhibitors to promote tumour immunity against glioblastomaShawn T Beug, Caroline E Beauregard, Cristin Healy, et al.Nature Communications|July 19, 2018
Publisher Correction: Smac mimetics synergize with immune checkpoint inhibitors to promote tumour immunity against glioblastomaShawn T Beug, Caroline E Beauregard, Cristin Healy, et al.BMC Cancer|March 5, 2021
Trastuzumab Emtansine (T-DM1) and stereotactic radiation in the management of HER2+ breast cancer brain metastasesMatthew N Mills, Chelsea Walker, Chetna Thawani, et al.Journal of Neuro-Oncology|August 11, 2019
CDK 4/6 inhibitors and stereotactic radiation in the management of hormone receptor positive breast cancer brain metastasesNicholas B Figura, Thrisha K Potluri, Homan Mohammadi, et al.Journal of Neuro-Oncology|March 20, 2021
Breast cancer subtype predicts clinical outcomes after stereotactic radiation for brain metastasesMatthew N Mills, Chetna Thawani, Nicholas B Figura, et al.Nature Communications|November 29, 2023
HDAC8-mediated inhibition of EP300 drives a transcriptional state that increases melanoma brain metastasisMichael F Emmons, Richard L Bennett, Alberto Riva, et al.Breast Cancer Research and Treatment|March 13, 2019
Clinical outcomes of breast leptomeningeal disease treated with intrathecal trastuzumab, intrathecal chemotherapy, or whole brain radiation therapyNicholas B Figura, Victoria T Rizk, Homan Mohammadi, et al.Pageof 11